Sun Pharmaceutical surges on launching special initiative ‘Sunkalp’ for welfare of doctors

01 Jul 2021 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 679.30, up by 3.80 points or 0.56% from its previous closing of Rs. 675.50 on the BSE.

The scrip opened at Rs. 675.50 and has touched a high and low of Rs. 681.25 and Rs. 673.60 respectively. So far 57678 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 721.90 on 11-May-2021 and a 52 week low of Rs. 452.60 on 29-Oct-2020.

Last one week high and low of the scrip stood at Rs. 683.40 and Rs. 666.10 respectively. The current market cap of the company is Rs. 163046.81 crore.

The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 33.29% and 12.23% respectively.

Sun Pharmaceutical Industries and includes its subsidiaries and/or associate companies) have launched special initiative ‘Sunkalp’ for the welfare of doctors, their families and the community. Doctors have been working relentlessly through the pandemic putting their lives at risk to safeguard society. To recognise and care for their health & well-being, on the occasion of National Doctors' Day, Sun Pharma launches multifaceted initiatives under Sunkalp.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.